相关实验视频

Updated: Jan 14, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

系统性硬化症相关的间歇性肺病患者的指甲毛细管镜检查:SENSCIS试验的一个子研究

Vanessa Smith¹, Christopher P Denton², Ariane L Herrick³

¹Ghent University Hospital, Department of Rheumatology, Ghent University, Department of Internal Medicine and Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Centre (IRC), Ghent, Belgium vanessa.smith@ugent.be.

|October 17, 2025

概括

在患有有系统性硬化症相关的间歇性肺病 (SSc-ILD) 并且有进展风险的患者中,宁达尼布可能有助于稳定指甲毛细血管密度. 需要进一步的研究来证实SSc-ILD患者的这些发现.

科学领域:

类风湿病学类风湿病学
肺部病理学肺部病理学
微血管医学是一种微血管医学.

背景情况:

系统性硬化症相关的间歇性肺病 (SSc-ILD) 涉及显著的微血管异常.
丁丁达尼布是SSc-ILD的批准治疗方法,但它对微血管系统的影响需要进一步研究.

研究的目的:

为了评估用宁泰达尼布治疗的SSc-ILD患者指甲毛细血管的微血管变化,与安慰剂对比.
评估宁泰达尼布对毛细血管密度和形态学在疾病进展方面的影响.

主要方法:

用指甲毛细血管镜 (NC) 评估毛细血管密度,巨毛细血管,异常形状和微出血在基线和52周.
患者根据快速强迫生命能力 (FVC) 衰退和间歇性肺病 (ILD) 进展的风险因素进行了分层.

主要成果:

总的来说,在任丁达尼布或安慰剂组中,没有观察到NC测量的显著变化.
在患有快速FVC下降的危险因素的患者中,毛细血管密度在忍者达尼布治疗中保持稳定,但在安慰剂治疗中数量下降.
在ILD进展的患者中,毛细血管密度在任泰达尼布治疗时数值增加,而在安慰剂治疗时保持稳定.

结论:

爪毛细管镜检查显示了52周毛细管密度变化中的数值差异.
这些发现表明,宁泰达尼布对SSc-ILD患者的微血管稳定性有潜在的有益影响,这些患者有进展风险.

关键词:

自免疫性疾病自免疫性疾病临床试验临床试验肺部疾病,间歇性疾病硬化皮质症,全身性硬化皮质症治疗方法治疗方法

更多相关视频

Non-Invasive Visualization of Nailbed Microvascular Morphology in Mice Using Capillaroscopy

Non-Invasive Visualization of Nailbed Microvascular Morphology in Mice Using Capillaroscopy

Published on: February 28, 2025

A Reproducible Computerized Method for Quantitation of Capillary Density using Nailfold Capillaroscopy

A Reproducible Computerized Method for Quantitation of Capillary Density using Nailfold Capillaroscopy

Published on: October 27, 2015

相关概念视频

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...